Microvesicle-based Solutions for Industrial, Environmental, and Personal Care Applications
Legal Citation
Summary of the Inventive Concept
The present inventive concept leverages the core technology of therapeutic microvesicles of probiotic bacteria to address pressing challenges in industrial wastewater treatment, indoor air quality, personal care, agriculture, and disease diagnosis.
Background and Problem Solved
The original patent focused on therapeutic microvesicles for human health. However, the potential of this technology extends far beyond healthcare. The inventive concept tackles the limitations of the original patent by applying the microvesicle technology to new, high-impact areas, where existing solutions are inadequate or non-existent.
Detailed Description of the Inventive Concept
The new claims encompass methods and systems for utilizing therapeutic microvesicles in industrial wastewater treatment to break down organic pollutants, in indoor air quality monitoring to detect and neutralize airborne pathogens, in personal care products for skin and hair care applications, in agriculture to enhance crop yields and disease resistance, and in diagnostics to detect biomarkers for early disease diagnosis. These applications harness the unique properties of microvesicles to provide innovative solutions.
Novelty and Inventive Step
The inventive concept's novelty lies in its application of microvesicle technology to entirely new fields, leveraging the original patent's core principles to address distinct problems. The inventive step resides in the unexpected yet effective use of microvesicles in these novel contexts.
Alternative Embodiments and Variations
Alternative embodiments may include variations in microvesicle composition, size, or surface modification to optimize their performance in different applications. Additionally, the use of different probiotic bacterial strains or combinations thereof could expand the range of potential applications.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential across multiple industries, including industrial wastewater treatment, air quality monitoring, personal care, agriculture, and diagnostics. The market for these applications is substantial, with opportunities for partnerships, licensing, and product development.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Microbiology, biotechnology, and probiotic bacterial engineering with focus on microvesicle production and therapeutic applications
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degree in microbiology or biotechnology, experienced in bacterial strain manipulation, microvesicle isolation techniques, and understanding of probiotic interactions with biological systems
Obviousness Rationale
A PHOSITA would recognize that the core microvesicle technology from the source patent provides a foundational platform for exploring diverse applications across multiple domains. The inherent properties of therapeutic microvesicles - such as their ability to interact with biological systems and carry molecular payloads - naturally suggest potential uses beyond the original medical context. Given the known versatility of probiotic bacterial microvesicles, extending their application to environmental, agricultural, and diagnostic domains represents a predictable and logical progression of the original technological concept.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,582 |
|---|---|
| Title | Therapeutic microvesicles of probiotic bacteria |
| Assignee(s) | BioGaia AB |